Soros Fund Management Llc
Source: SEC Form 13F · as of Mar 2026Soros Fund Management Llc holds 13 biotech & pharma companies tracked by BioSniper, totaling $272.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$272.6M
| Company | Shares | Value |
|---|---|---|
| FOLDAMICUS THERAPEUTICS, INC. | 5,753,186 | $83.2M |
| APLSApellis Pharmaceuticals, Inc. | 1,056,000 | $42.5M |
| DAWNDay One Biopharmaceuticals, Inc. | 1,539,100 | $33.0M |
| ACLXArcellx, Inc. | 200,000 | $23.0M |
| LLYELI LILLY & Co | 22,199 | $20.4M |
| PMPhilip Morris International Inc | 112,294 | $18.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 64,993 | $17.6M |
| TERNTerns Pharmaceuticals, Inc. | 321,905 | $17.0M |
| JNJJOHNSON & JOHNSON | 34,846 | $8.5M |
| ABTABBOTT LABORATORIES | 44,750 | $4.6M |
| ARRYARRAY BIOPHARMA INC | 275,286 | $2.0M |
| AKTSAktis Oncology Inc. | 100,000 | $1.8M |
| ACHCAcadia Healthcare Company Inc. | 22,536 | $527K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.